General Interest News
November 30, 2007
Biotech Law Weekly
Research from University of Naples Provides New Data on Homeopathy"In the last decade, we have investigated from the physicochemical point of view, whether water prepared by the procedures of homeopathic medicine (leading inexorably to systems without any molecule different from the solvent) results in water different from the initial water? The answer, unexpectedly, but strongly supported by many experimental results is positive. We used well-established physicochemical techniques: flux calorimetry, concluctometry, pHmetry and galvanic cell electrodes potential," researchers in Naples, Italy report.
"Unexpectedly the physicochemical parameters evolve in time. The water solvent exhibits large changes in measurable physicochernical properties as a function of its history, the solute previously dissolved, and time. In particular we found evidence of two new phenomena, both totally unpredicted, in homeopathic dilutions: the presence of a maximum in the measured physicochernical parameters vs sample age, and their dependence on the volume in which the dilution is stored," wrote V. Elia and colleagues, University of Naples.
The researchers concluded: "These new experimental results strongly suggest the presence of an extended and 'ordered' dynamics involving liquid water molecules."
Elia and colleagues published their study in Homeopathy (The 'memory of water': an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy, 2007;96(3):163-169).”
November 30, 2007
Biotech Law Weekly
Studies from Pennsylvania State University Reveal New Findings on Chemistry“According to recent research from the United States, "The key stumbling block to serious consideration of homeopathy is the presumed ''implausibility'' of biological activity for homeopathic medicines in which the source material is diluted past Avogadro's number of molecules. Such an argument relies heavily on the assumptions of elementary chemistry (and biochemistry), in which the material composition of a solution, (dilution factors and ligand-receptor interactions), is the essential consideration."
"In contrast, materials science focuses on the three-dimensional complex network structure of the condensed phase of water itself, rather than the original solute molecules. The nanoheterogenous structure of water can be determined by interactive phenomena such as epitaxy (the transmission of structural information from the surface of one material to another without the transfer of any matter), temperature-pressure processes during succussion, and formation of colloidal nanobubbles containing gaseous inclusions of oxygen, nitrogen, carbon dioxide, and possibly the remedy source material. Preliminary data obtained using Raman and Ultra-Violet-Visible (UV-VIS) spectroscopy illustrate the ability to distinguish two different homeopathic medicines (Nux vomica and Natrurn muriaticum) from one another and to differentiate, within a given medicine, the 6c, 12c, and 30c potencies," wrote M.L. Rao and colleagues, Pennsylvania State University.
The researchers concluded: "Materials science concepts and experimental tools offer a new approach to contemporary science, for making significant advances in the basic science studies of homeopathic medicines."
Rao and colleagues published their study in Homeopathy (The defining role of structure (Including epitaxy) in the plausibility of homeopathy. Homeopathy, 2007;96(3):175-182).”
Posted December 15/2005
Six Year Study Shows Homeopathic Benefit in Chronic Disease
From BBC news Monday November 21/2005
A six-year study at Bristol Homeopathic Hospital shows over 70% of patients with chronic diseases reported positive health changes after treatment.More than 6,500 patients took part in the study with problems ranging from eczema to menopause and arthritis.The biggest improvements were seen in children - 89% of under 16s with asthma reported improvement.Of the group, 75% felt 'better' or 'much better', as did 68% of eczema patients under 16.
Posted December 4/2005
HAS THE AVIAN FLU MUTATION ARRIVED?
Leaders of homeopathic organizations from 17 countries recently met in Paris to discuss the homeopathic response to the anticipated pandemic of a mutated form of avian flu. Although such a pandemic does not yet exist it is regarded by respected
researches as inevitable. Homeopathy has an outstanding track record in the treatment of the flu. Shortly a website will be created as an information center for homeopaths if a pandemic does evolve. The Homeopathic Treatment of Influenza by Sandra Perko has an excellent discussion of the avian flu issue and why it is a legitimate concern.
Posted: November 13/2005
SAN JOSE NCH CONVENTION
Plans are full steam ahead for the first joint conference of homeopathic orgnanizations which is to be held in San Jose,CA,April 7-11, 2006. Representatives from the professional organizations - NASH, AIH, HANP, AVH and HNA - have reviewed and selected the list of speakers. The HANP and other associations will each carry on their annual membership conferences in the course of the convention.
Friday April seventh the HANP will hold a series of membership meetings. These will include the CNCHE (Council of Naturopathic College Homeopathic Educators), HANP student reps and students, HANP general membership, and the HANP board. Saturday and Sunday will feature a great variety of lectures in both the general and advanced tracks. The Advanced Conference on Monday and Tuesday will feature Nancy Herrick and Roger Morrison. Richard Pitcairn will lead a veterinary workshop on Monday.
A collection of articles, responses and information related to the Lancet article (Vol 366, 27 August 2005): "Are the Clinical Effects of Homeopathy Placebo Effects? Comparative Study of Placebo Controlled Trials of Homeopathy and Allopathy" by various authors www.homeopathycourses.com/lancet.html
European Journal of Pediatrics
Publisher: Springer-Verlag GmbH
ISSN: 0340-6199 (Paper) 1432-1076 (Online)
Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial
Heiner Frei1, Regula Everts2, Klaus von Ammon3, Franz Kaufmann2, Daniel Walther2, Shu-Fang Hsu-Schmitz4, Marco Collenberg4, Katharina Fuhrer2, Ralph Hassink5, Maja Steinlin2 Contact Information and André Thurneysen3 Contact Information (1) Swiss Association of Homeopathic Physicians SAHP, Lucerne, Switzerland (2) Division of Paediatric Neurology, University Childrenrsquos Hospital, Inselspital, 010 Berne, Switzerland (3) Kollegiale Instanz für Komplementärmedizin (KIKOM)/Homeopathy, Imhoof Pavillon, Inselspital, 3010 Berne, Switzerland (4) Department of Mathematical Statistics and Actuarial Science (IMSV), University of Berne, Berne, Switzerland (5) Zentrum für Entwicklungsförderung und pädiatrische Neurorehabilitation, Bienne, Switzerland
Received: 8 March 2005 Revised: 23 May 2005 Accepted: 1 June 2005 Published online: 27 July 2005
Abstract An increasing number of parents turn to homeopathy for treatment of their hyperactive child. Two publications, a randomised, partially blinded trial and a clinical observation study, conclude that homeopathy has positive effects in patients with attention deficit hyperactivity disorder (ADHD). The aim of this study was to obtain scientific evidence of the effectiveness of homeopathy in ADHD. A total of 83 children aged 6-16 years, with ADHD diagnosed using the Diagnostic and Statistical Manual of Mental Disorders-IV criteria, were recruited. Prior to the randomised, double blind, placebo controlled crossover study, they were treated with individually prescribed homeopathic medications. 62 patients, who achieved an improvement of 50% in the Connersrsquo Global Index (CGI), participated in the trial. Thirteen patients did not fulfill this eligibility criterion (CGI). The responders were split into two groups and received either verum for 6 weeks followed by placebo for 6 weeks (arm A), or vice-versa (arm B). At the beginning of the trial and after each crossover period, parents reported the CGI and patients underwent neuropsychological testing. The CGI rating was evaluated again at the end of each crossover period and twice in long-term follow-up. At entry to the crossover trial, cognitive performance such as visual global perception , impulsivity and divided attention, had improved significantly under open label treatment ( P<0.0001). During the crossover trial, CGI parent-ratings were significantly lower under verum (average 1.67 points) than under placebo ( P =0.0479). Long-term CGI improvement reached 12 points (63%, P <0.0001).
Conclusion:The trial suggests scientific evidence of the effectiveness of homeopathy in the treatment of attention deficit hyperactivity disorder, particularly in the areas of behavioural and cognitive functions.
Homeopathy and Influenza
In the last half-decade we have seen increasing media promotion of influenza vaccination. In 2005 this seems to have been replaced by dramatic reports of the potential for a world wide avian flu pandemic. Although classical homeopathic methods in the treatment of influenza derive tremendous circumstantial and historical support, there is very little modern research. Reseach has focussed on a single propriety homeopathic medicine made from the livers and hearts of a species of duck known for storing influenza viruses. This completely safe and widely used homeopathic preparation has not had homeopathic provings but has been the subject of various studies that indicate its value in reducing the severity of influenza.
Research regarding Oscillococcinum (Boiron laboratories): A double-blind, placebo-controlled pilot study of 100 patients showed that, when given at the onset of influenza-like symptoms, Oscillococcinum worked better than the placebo in reducing the symptoms of chills (85.7% vs. 57.1%), stiffness (72.5% vs. 41.9%) and fever (79.1% vs. 40%). Also 80% of patients given Oscillococcinum reported the treatment to be a success vs. 38% in the placebo group.
In a double-blind, clinical trial of 05 patients with influenza-like symptoms, 55% of the patients taking Oscillococcinum reported no chills after four days, compared with 27% of the placebo- controlled group. More patients in the Oscillococcinum group also reported no aches after four days-70% were ache-free compared with 48% in the placebo group. Fever in the Oscillococcinum group was significantly lower starting on the I second day of the treatment, compared to the placebo group.
In a double-blind, clinical trial of 478 patients published in The British Journal of Clinical Pharmacology in 1989, researchers studied Oscillococcinum's effect on nine influenza-like symptoms-fever, headaches, stiffness, lumbar and particular pain, shivers, cough, coryza and fatigue - versus a placebo. The proportion of patients who recovered within 48 hours of treatment was significantly superior among the Oscillococcinum group than the placebo group.
A recent double-blind, clinical trial of 372 patients performed by f researchers at a German University and published in April 1998 yielded results similar to those published in the British Journal of Clinical Pharmacology (above). The complete disappearance of symptoms after 48 hours was significantly superior among the Oscillococcinum group than among the placebo group. This clinical trial also showed that treatment of influenza-like symptoms with Oscillococcinum has positive effect on the decline of symptoms and on the duration of the disease.